Drugs / Doxofylline

Trials 5

20092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT03879590 May → Sep 2019 childhood onset asthma, chronic asthma Autonomous University of Nuevo León Unknown No outcome recorded
Phase 43 trials
Phase 4 NCT04238221 Dec 2026 → Dec 2027 expected chronic obstructive pulmonary disease University of Milan Not yet recruiting No outcome recorded
Phase 4 NCT06346691 Mar → Oct 2024 chronic obstructive pulmonary disease Thammasat University Completed No outcome recorded
Phase 4 NCT03388853 Feb 2018 → Dec 2019 chronic obstructive pulmonary disease Neutec Ar-Ge San ve Tic A.Ş Completed No outcome recorded
Phase not applicable1 trial
— NCT01055041 Dec 2008 → Jun 2009 chronic asthma Government Medical College, Bhavnagar Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as Doxofylline ClinicalTrials.gov intervention name — accepted as the source's own label NCT06346691 ↗
2

NCT03388853 ↗

NCT04238221 ↗

Known as ABC 12/3 ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608 ↗
Known as Ansimar ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608 ↗
Known as Dioxyfilline ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608 ↗
Known as Doxofilina ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608 ↗
Known as Doxophylline ClinicalTrials.gov intervention name — accepted as the source's own label NCT03879590 ↗
1

NCT01055041 ↗

Known as NSC-759645 ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608 ↗
Known as Synasma ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608 ↗
Known as Ventax ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608 ↗
Modality Small molecule — CHEMBL1527608 ↗
Route Oral “plus tablet doxophylline sustained release(400 mg/day)orally in the morning” NCT01055041 ↗